ReP USP - Resultado da busca

Artigo de periodico
Long-term symptoms among COVID-19 survivors in prospective cohort study, Brazil (2022)
Bonifácio, Lívia Pimenta ; Csizmar, Viviane N.F.; Barbosa-Júnior, Francisco; Pereira, Ana P. S.; Koenigkam-Santos, Marcel; Wada, Danilo T.; Gaspar, Gilberto G.; Carvalho, Felipe S.; Bollela, Valdes Roberto; Santana, Rodrigo C.; Souza, João Paulo Dias de; Bellissimo-Rodrigues, Fernando
Source: Emerging Infectious Diseases. Unidade: FMRP
Subjects: COVID-19, ESTUDOS PROSPECTIVOS, SOBREVIVÊNCIA LIVRE DE DOENÇA, EPIDEMIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BONIFÁCIO, Lívia Pimenta et al. Long-term symptoms among COVID-19 survivors in prospective cohort study, Brazil. Emerging Infectious Diseases, v. 28, n. 3, p. 730-733, 2022Tradução . . Disponível em: https://doi.org/10.3201/eid2803.212020. Acesso em: 06 nov. 2024.
APA
Bonifácio, L. P., Csizmar, V. N. F., Barbosa-Júnior, F., Pereira, A. P. S., Koenigkam-Santos, M., Wada, D. T., et al. (2022). Long-term symptoms among COVID-19 survivors in prospective cohort study, Brazil. Emerging Infectious Diseases, 28( 3), 730-733. doi:10.3201/eid2803.212020
NLM
Bonifácio LP, Csizmar VNF, Barbosa-Júnior F, Pereira APS, Koenigkam-Santos M, Wada DT, Gaspar GG, Carvalho FS, Bollela VR, Santana RC, Souza JPD de, Bellissimo-Rodrigues F. Long-term symptoms among COVID-19 survivors in prospective cohort study, Brazil [Internet]. Emerging Infectious Diseases. 2022 ; 28( 3): 730-733.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3201/eid2803.212020
Vancouver
Bonifácio LP, Csizmar VNF, Barbosa-Júnior F, Pereira APS, Koenigkam-Santos M, Wada DT, Gaspar GG, Carvalho FS, Bollela VR, Santana RC, Souza JPD de, Bellissimo-Rodrigues F. Long-term symptoms among COVID-19 survivors in prospective cohort study, Brazil [Internet]. Emerging Infectious Diseases. 2022 ; 28( 3): 730-733.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3201/eid2803.212020
Artigo de periodico
Oral vinorelbine and cisplatin as first-line therapy for advanced squamous NSCLC patients: a prospective randomized international phase II study (NAVoTrial 03) (2021)
Grossi, Francesco; Jaskiewicz, Piotr; Ferreira, Marion; Czyzewicz, Grzegorz; Kowalski, Dariusz; Ciuffreda, Libero; Garcia-gomez, Ramon; Caruso, Salvatore; Bosch-barrera, Joaquim; Gautier, Stephanie; Castro Junior, Gilberto de Castro
Source: Therapeutic advances in medical oncology. Unidade: FM
Subjects: ESTUDOS PROSPECTIVOS, NEOPLASIAS PULMONARES (TERAPIA), SOBREVIVÊNCIA LIVRE DE DOENÇA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GROSSI, Francesco et al. Oral vinorelbine and cisplatin as first-line therapy for advanced squamous NSCLC patients: a prospective randomized international phase II study (NAVoTrial 03). Therapeutic advances in medical oncology, v. 13, 2021Tradução . . Disponível em: https://doi.org/10.1177/17588359211022905. Acesso em: 06 nov. 2024.
APA
Grossi, F., Jaskiewicz, P., Ferreira, M., Czyzewicz, G., Kowalski, D., Ciuffreda, L., et al. (2021). Oral vinorelbine and cisplatin as first-line therapy for advanced squamous NSCLC patients: a prospective randomized international phase II study (NAVoTrial 03). Therapeutic advances in medical oncology, 13. doi:10.1177/17588359211022905
NLM
Grossi F, Jaskiewicz P, Ferreira M, Czyzewicz G, Kowalski D, Ciuffreda L, Garcia-gomez R, Caruso S, Bosch-barrera J, Gautier S, Castro Junior G de C. Oral vinorelbine and cisplatin as first-line therapy for advanced squamous NSCLC patients: a prospective randomized international phase II study (NAVoTrial 03) [Internet]. Therapeutic advances in medical oncology. 2021 ; 13[citado 2024 nov. 06 ] Available from: https://doi.org/10.1177/17588359211022905
Vancouver
Grossi F, Jaskiewicz P, Ferreira M, Czyzewicz G, Kowalski D, Ciuffreda L, Garcia-gomez R, Caruso S, Bosch-barrera J, Gautier S, Castro Junior G de C. Oral vinorelbine and cisplatin as first-line therapy for advanced squamous NSCLC patients: a prospective randomized international phase II study (NAVoTrial 03) [Internet]. Therapeutic advances in medical oncology. 2021 ; 13[citado 2024 nov. 06 ] Available from: https://doi.org/10.1177/17588359211022905
Trabalho de evento-resumo periodico
Evaluation of the long-term impact of COVID-19 on the quality of life among disease survivors: preliminary results of a prospective cohort study (Recovida) (2021)
Bonifacio, L.; Barbosa Júnior, Fernando; Csizmar, Viviane Nunes Ferreira; Pereira, Amanda Polin; Carvalho, F.; Guioti, F.; Dal-Fabbro, Amaury Lelis ; Souza, J. P.; Bellíssimo-Rodrigues, Fernando
Source: Antimicrobial Resistance & Infection Control. Conference titles: International Conference on Prevention & Infection Control (ICPIC 2021). Unidades: FCFRP, FMRP
Subjects: COVID-19, SOBREVIVÊNCIA LIVRE DE DOENÇA, QUALIDADE DE VIDA, ESTUDOS DE COORTES, ESTUDOS PROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BONIFACIO, L. et al. Evaluation of the long-term impact of COVID-19 on the quality of life among disease survivors: preliminary results of a prospective cohort study (Recovida). Antimicrobial Resistance & Infection Control. London: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://aricjournal.biomedcentral.com/track/pdf/10.1186/s13756-021-00974-z.pdf. Acesso em: 06 nov. 2024. , 2021
APA
Bonifacio, L., Barbosa Júnior, F., Csizmar, V. N. F., Pereira, A. P., Carvalho, F., Guioti, F., et al. (2021). Evaluation of the long-term impact of COVID-19 on the quality of life among disease survivors: preliminary results of a prospective cohort study (Recovida). Antimicrobial Resistance & Infection Control. London: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Recuperado de https://aricjournal.biomedcentral.com/track/pdf/10.1186/s13756-021-00974-z.pdf
NLM
Bonifacio L, Barbosa Júnior F, Csizmar VNF, Pereira AP, Carvalho F, Guioti F, Dal-Fabbro AL, Souza JP, Bellíssimo-Rodrigues F. Evaluation of the long-term impact of COVID-19 on the quality of life among disease survivors: preliminary results of a prospective cohort study (Recovida) [Internet]. Antimicrobial Resistance & Infection Control. 2021 ; 10 133.[citado 2024 nov. 06 ] Available from: https://aricjournal.biomedcentral.com/track/pdf/10.1186/s13756-021-00974-z.pdf
Vancouver
Bonifacio L, Barbosa Júnior F, Csizmar VNF, Pereira AP, Carvalho F, Guioti F, Dal-Fabbro AL, Souza JP, Bellíssimo-Rodrigues F. Evaluation of the long-term impact of COVID-19 on the quality of life among disease survivors: preliminary results of a prospective cohort study (Recovida) [Internet]. Antimicrobial Resistance & Infection Control. 2021 ; 10 133.[citado 2024 nov. 06 ] Available from: https://aricjournal.biomedcentral.com/track/pdf/10.1186/s13756-021-00974-z.pdf
Trabalho de evento-resumo periodico
Evaluation of long-term clinical findings among COVID-19 survivors: preliminary results of a prospective cohort study (Recovida) (2021)
Bonifacio, L.; Csizmar, Viviane Nunes Ferreira; Pereira, Amanda Polin; Barbosa Júnior, Fernando; Bollela, Valdes Roberto; Santana, Rodrigo de Carvalho; Souza, J. P.; Bellíssimo-Rodrigues, Fernando
Source: Antimicrobial Resistance & Infection Control. Conference titles: International Conference on Prevention & Infection Control (ICPIC 2021). Unidades: FMRP, FCFRP
Subjects: COVID-19, SOBREVIVÊNCIA LIVRE DE DOENÇA, ASSISTÊNCIA MÉDICA, ESTUDOS DE COORTES, ESTUDOS PROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BONIFACIO, L. et al. Evaluation of long-term clinical findings among COVID-19 survivors: preliminary results of a prospective cohort study (Recovida). Antimicrobial Resistance & Infection Control. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://aricjournal.biomedcentral.com/track/pdf/10.1186/s13756-021-00974-z.pdf. Acesso em: 06 nov. 2024. , 2021
APA
Bonifacio, L., Csizmar, V. N. F., Pereira, A. P., Barbosa Júnior, F., Bollela, V. R., Santana, R. de C., et al. (2021). Evaluation of long-term clinical findings among COVID-19 survivors: preliminary results of a prospective cohort study (Recovida). Antimicrobial Resistance & Infection Control. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Recuperado de https://aricjournal.biomedcentral.com/track/pdf/10.1186/s13756-021-00974-z.pdf
NLM
Bonifacio L, Csizmar VNF, Pereira AP, Barbosa Júnior F, Bollela VR, Santana R de C, Souza JP, Bellíssimo-Rodrigues F. Evaluation of long-term clinical findings among COVID-19 survivors: preliminary results of a prospective cohort study (Recovida) [Internet]. Antimicrobial Resistance & Infection Control. 2021 ; 10 133-134.[citado 2024 nov. 06 ] Available from: https://aricjournal.biomedcentral.com/track/pdf/10.1186/s13756-021-00974-z.pdf
Vancouver
Bonifacio L, Csizmar VNF, Pereira AP, Barbosa Júnior F, Bollela VR, Santana R de C, Souza JP, Bellíssimo-Rodrigues F. Evaluation of long-term clinical findings among COVID-19 survivors: preliminary results of a prospective cohort study (Recovida) [Internet]. Antimicrobial Resistance & Infection Control. 2021 ; 10 133-134.[citado 2024 nov. 06 ] Available from: https://aricjournal.biomedcentral.com/track/pdf/10.1186/s13756-021-00974-z.pdf

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Indexado em